<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01694134</url>
  </required_header>
  <id_info>
    <org_study_id>8833</org_study_id>
    <nct_id>NCT01694134</nct_id>
  </id_info>
  <brief_title>Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.</brief_title>
  <acronym>MODISC</acronym>
  <official_title>Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment of chronic low back pain is a major objective of public healthcare, because it
      causes an important number of sick leaves. A correlation between clinical observations and an
      inflammatory discopathy has been underlined, but there is currently any reference treatment.
      In this study, the main objective is to assess the efficacy of an intradiscal injection of
      corticoids versus local anaesthetic on the treatment of pain of patients with low back pain
      associated to a Modic I discopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, controlled, single-blind with two arms (anaesthetic versus corticoids)
      trial.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain assessment</measure>
    <time_frame>6 months</time_frame>
    <description>The pain will be assessed by the visual analog scale (VAS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of life will be assessed by the self-questionnaire SF-36.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of analgesics and NSAIDs assessment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific low back pain parameters assessment</measure>
    <time_frame>6 months</time_frame>
    <description>Low back pain parameters will be assessed by the Dallas scale and the Oswestry scale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Low Back Pain</condition>
  <condition>Lumbago</condition>
  <condition>Modic I Discopathy</condition>
  <arm_group>
    <arm_group_label>Corticoids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A group of patients will receive an intradiscal injection of Hydrocortancyl.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anaesthetic</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>A group of patients will receive an intradiscal injection of Lidocaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortancyl.</intervention_name>
    <description>Patients will receive an intradiscal injection of hydrocortancyl.</description>
    <arm_group_label>Corticoids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <arm_group_label>Local anaesthetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 80 years

          -  Signed Informed consent

          -  Low back pain for more than 6 months associated with Modic I discopathy (diagnosed by
             MRI)

        Exclusion Criteria:

          -  Past history of lumbar surgery

          -  Patient under anticoagulant or antisludge treatment, or with coagulation troubles

          -  Patient with unbalanced diabetes mellitus (blood glucose &gt; 1.30 g/l)

          -  Patient with unstabilized high blood pressure (&gt; 160/95 mmHg)

          -  Patient with evolving infection

          -  Patient with iodine allergy or one of the HydrocortancylÂ® or Lidocaine components

          -  Porphyria, hypersensitivity to local anaesthetic

          -  Patient with sphincter troubles showing a cauda equine syndrome

          -  Untreated psychotic state

          -  Pregnant women or of childbearing age without effective contraception means

          -  Impossible 6 months follow-up

          -  Participation to another trial

          -  Vulnerable persons protected by the law

          -  Persons under guardianship

          -  Persons unable to express their consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Isabelle Tavares, MD</last_name>
    <phone>+334 67 33 88 26</phone>
    <email>i-tavaresfigueiredo@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital University of Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Tavares, MD</last_name>
      <phone>+334 67 33 88 26</phone>
      <email>i-tavaresfigueiredo@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle Tavares, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2012</study_first_submitted>
  <study_first_submitted_qc>September 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2012</study_first_posted>
  <last_update_submitted>May 31, 2016</last_update_submitted>
  <last_update_submitted_qc>May 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Discopathy</keyword>
  <keyword>Modic I</keyword>
  <keyword>Corticoids</keyword>
  <keyword>Local Anaesthetic</keyword>
  <keyword>Intradiscal injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Intervertebral Disc Displacement</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

